Drug Shortage Report for SURVANTA
Report ID | 226027 |
Drug Identification Number | 02016109 |
Brand name | SURVANTA |
Common or Proper name | Survanta |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | BERACTANT |
Strength(s) | 25MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRATRACHEAL INTRATRACHEAL |
Packaging size | 4mL and 8 mL |
ATC code | R07AA |
ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-04-29 |
Estimated end date | 2024-05-14 |
Actual end date | 2024-05-10 |
Shortage status | Resolved |
Updated date | 2024-05-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2024-05-11 | English | Compare |
v14 | 2024-05-10 | French | Compare |
v13 | 2024-05-10 | English | Compare |
v12 | 2024-05-01 | French | Compare |
v11 | 2024-05-01 | English | Compare |
v10 | 2024-04-30 | English | Compare |
v9 | 2024-04-29 | French | Compare |
v8 | 2024-04-29 | English | Compare |
v7 | 2024-04-26 | French | Compare |
v6 | 2024-04-26 | English | Compare |
v5 | 2024-04-24 | English | Compare |
v4 | 2024-04-24 | French | Compare |
v3 | 2024-04-24 | English | Compare |
v2 | 2024-04-24 | French | Compare |
v1 | 2024-04-24 | English | Compare |
Showing 1 to 15 of 15